Nature Reviews Nephrology

Nature Reviews Nephrology (commonly abbreviated as Nat. Rev. Nephrol.) is a nephrology review journal published by Springer Nature. It was founded in November 2005 as Nature Clinical Practice Nephrology, took its current title in April 2009, is issued monthly, is an official journal of the International Society of Nephrology, and had an impact factor of 46.7 in 2025.Nature Reviews Nephrology（常用缩写 Nat. Rev. Nephrol.）是 Springer Nature 旗下肾脏病学领域的综述类期刊，2005 年 11 月以 Nature Clinical Practice Nephrology 之名创刊，2009 年 4 月改用现名，按月刊出版，是国际肾脏病学会的官方期刊，2025 年影响因子为 46.7。^[1]

Scope

• Disciplinary focus: the journal aims to be the premier source of reviews and commentaries for the scientific communities it serves. Articles are meant to be authoritative and accessible, enhanced with clearly understandable figures, tables and other display items, and the editorial team works hard to maximize the usefulness and impact of every article.学科定位： 期刊以成为所服务科学共同体在综述与评论方面的首要来源为目标；文章力求权威而易读，并配有清晰易懂的图表与展示材料，编辑团队尽力让每一篇文章都发挥最大的效用与影响力。
• Subjects covered: the scope spans all areas concerned with the prevention, diagnosis and treatment of disorders of the kidney in adults and children, including hypertension, infection, inflammation, dialysis, chronic uraemia, renal failure, transplantation, applied physiology, epidemiology, pathology, immunology, cancer and genetics.选题范围： 覆盖成人与儿童肾脏疾病的一切防治领域，包括高血压、感染与炎症、透析与慢性尿毒症、肾功能衰竭、移植、应用生理学、流行病学、病理学、免疫学、癌症与遗传学。
• Content types: the journal publishes Research Highlights, News & Views, Comments, Reviews, Perspectives and Consensus Statements for nephrologists and basic science researchers, together with educational Case Studies that help readers carry the evidence into concrete diagnostic and therapeutic situations.体裁： 刊发研究亮点、新闻与观点、评论、综述、观点文章与共识声明，面向肾脏病学家与基础科学研究者，另有教学性的病例研究栏目帮助读者把文献证据落到具体的诊疗情境。
• Audience: as the volume of original clinical research continues to grow, it has become increasingly difficult to keep up to date while still devoting substantial time to patient care. The journal addresses busy clinicians and researchers by offering timely authoritative interpretations of key research developments that translate the latest findings into clinical practice.读者对象： 鉴于原始临床研究的数量持续增长，临床医生在投入照护工作的同时已越来越难以跟进文献，期刊以向忙碌的临床医生与研究者提供及时而权威的文献解读、把最新发现转译为临床实践为出发点。
• Commissioned model and open access: articles can only be published using the subscription route, and the publisher offers no immediate gold open access option and charges no publication fee. Reviews and Perspectives are written by external authors invited or commissioned by the in-house editors, authors may submit proposals for Review-type and Comment-type articles through the online submission system, and the great majority of published content is commissioned.约稿模型与开放获取： 文章只能按订阅方式出版，出版方不提供立即开放获取选项，也不收取版面费；综述与观点文章由编辑部邀请或约请领域内的学者撰写，作者可在在线投稿系统中提交综述类与评论类的选题提案，但刊载内容以约稿为绝对主体。

History

• November 2005: Nature Publishing Group and the International Society of Nephrology jointly launched Nature Clinical Practice Nephrology for readers interested in clinical kidney disease and hypertension, with Robert W. Schrier as founding Editor-in-Chief. An advisory board was assembled at the same time, bringing expertise across acute kidney injury, chronic kidney disease, diabetic and metabolic disorders, hypertension, dialysis, transplantation, hereditary kidney disease, paediatric nephrology, and fluid, acid-base and electrolyte disorders.2005年11月： 自然出版集团与国际肾脏病学会共同创刊 Nature Clinical Practice Nephrology，面向对临床肾病与高血压有兴趣的读者，创刊主编为 Robert W. Schrier，并同时组建了一支汇集急性肾损伤、慢性肾病、糖尿病与代谢病、高血压、透析、移植、遗传性肾病、儿科肾脏病以及体液酸碱与电解质紊乱专长的顾问委员会。
• Society affiliation: the journal has been an official journal of the International Society of Nephrology from the outset, and society members enjoy free online access. The society's own achievements, such as its lobbying that led the United Nations to recognize chronic kidney disease as an important noncommunicable disease in its own right, have likewise been recorded and supported in these pages.学会合作： 自创刊起本刊一直是国际肾脏病学会的官方期刊，学会会员可免费在线阅读；该学会在推动慢性肾病被联合国确认为独立的重要非传染性疾病等方面的工作，也曾在本刊中得到专门记述与支持。
• April 2009: the publisher rebranded eight clinical journals under the Nature Reviews name, and this title became Nature Reviews Nephrology to align more closely with the life-science Nature Reviews journals. The changes included better figures and full-colour printing, Research Highlights supplemented by brief vignettes of recent advances, the former practice points section recast as News & Views, and an increase in the number of clinical Reviews written by international experts.2009年4月： 出版方把八本临床类刊物统一改冠 Nature Reviews 品牌，本刊自此定名为 Nature Reviews Nephrology，以更贴近自然出版集团生命科学评论系列的整体面貌；改版内容包括提升插图质量与改为全彩印刷，研究亮点栏目新增了简短的进展短评，原有的诊疗要点栏目改为新闻与观点，国际专家撰写的临床综述数量也相应增加。
• Editorial continuity: after completing his five-year founding term, Robert W. Schrier was succeeded by Susan Allison. The journal has retained an external advisory board alongside the in-house team of full-time editors employed by Nature Publishing Group.编委沿革： 首任主编 Robert W. Schrier 完成了创刊前五年的任期后由 Susan Allison 接任；本刊保留了外部顾问委员会这一机制，与自然出版集团内部的全职编辑团队并存。
• Publisher and reach: Nature Publishing Group was first a publishing division of Macmillan, and in 2015 it merged with the Springer Science and Business Media Group, so the title is now published under the Springer Nature name. The impact factor peaked at 42.439 in 2021 and stood at 46.7 in 2025, keeping the journal among the most highly ranked titles in urology and nephrology.出版方与影响力： 自然出版集团先为麦克米伦旗下的出版部门，后于 2015 年与施普林格科学与商业出版集团合并，今日以 Springer Nature 名义出版；期刊影响因子在 2021 年达到 42.439 的高点，2025 年升至 46.7，在泌尿学与肾脏学类期刊中位居前列。^[2]

Editors

• Chief Editor: the journal is led by Susan Allison, who took an honours degree in biochemistry at the University of Otago in New Zealand, earned her PhD at the Garvan Institute of Medical Research in Sydney with work on the mechanisms of anabolic bone formation, and went on to postdoctoral research at the Stem Cell Institute at Lund University in Sweden. She entered publishing as an Associate Editor on Nature Reviews Gastroenterology & Hepatology in 2008, became Chief Editor here in 2009, and has also served as a Consulting Editor for Springer Nature since June 2020.主编： 现任主编为 Susan Allison，她在新西兰奥塔哥大学完成生物化学荣誉学士学业、在悉尼的加文医学研究所取得博士学位并研究促成骨形成的机制，随后赴瑞典隆德大学的干细胞研究所从事博士后研究；2008 年以副编辑身份加入 Nature Reviews Gastroenterology & Hepatology，2009 年出任本刊主编，2020 年 6 月起兼任 Springer Nature 的咨询编辑。
• Senior Editors: Ellen Carney PhD and Monica Wang PhD serve as Senior Editors, both based in the London office. The former trained at the University of Dundee and the University of Birmingham and joined this journal in 2012 before being promoted to Senior Editor in 2014, while the latter joined in July 2018.高级编辑： Ellen Carney 博士与 Monica Wang 博士担任高级编辑，两人均常驻伦敦办公室，前者在邓迪大学与伯明翰大学受训并于 2012 年加入本刊、2014 年升任高级编辑，后者于 2018 年 7 月加入。
• External advisory board: the journal has an external advisory board that offers advice and support, drawn from internationally renowned nephrologists. The journal notes alongside this that all editorial decisions are made by the team of full-time professional editors, so the advisory board does not take the decisions itself.外部顾问： 期刊设有一支外部顾问委员会提供建议与支持，委员多为本领域的国际知名肾脏病学家；期刊同时说明，所有编辑决定仍由全职专业编辑团队作出，外部顾问委员会不参与决策。
• Chinese edition: the journal also publishes a Chinese edition, overseen by a Chinese editorial board of nephrologists and issued alongside the English edition, giving Chinese-language readers a separate editorial route into the content.中文版： 期刊曾发行中文版，由国内多位肾脏病学家组成的中文版编委会主持，与英文版同期出版，为中文读者提供了独立的编辑入口。
• Submissions and contact: manuscripts and proposals are submitted through the Nature Publishing Group online submission and tracking system, where a proposal requires only a single article file. General editorial inquiries and status queries go to the journal's editorial office email address.投稿与联系： 稿件与选题提案通过自然出版集团的在线投稿与追踪系统提交，提交提案时只需上传一份文章文件，一般编辑问询与稿件状态查询可发信至期刊的编辑部邮箱。^[3]